First Trust Direct Indexing’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-558
Closed -$9K 432
2020
Q4
$9K Buy
+558
New +$7.08K ﹤0.01% 931

Other funds holding ANGO

First Trust Direct Indexing's ANGO Position: Q1 2021 in Review

First Trust Direct Indexing sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 558 shares — an estimated $9K sold.

First Trust Direct Indexing first reported a position in ANGO in Q4 2020 and held it in 1 quarter. The position peaked at $9K in Q4 2020. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.

  • First Trust Direct Indexing reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
  • First Trust Direct Indexing sold 558 AngioDynamics shares in Q1 2021, an estimated $9K.
  • First Trust Direct Indexing first reported a position in AngioDynamics in Q4 2020 and held it in 1 quarter.
  • First Trust Direct Indexing's AngioDynamics position peaked at $9K in Q4 2020.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.

Based on First Trust Direct Indexing's 13F filing for Q1 2021, filed 14 Apr 2021.